Status:
RECRUITING
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
Lead Sponsor:
University of California, San Diego
Conditions:
Contraception
Pain, Acute
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The goal of this research study is to learn more about how different uses of a numbing medication might affect pain levels while getting an IUD placed. The investigators are also studying participants...
Detailed Description
Lidocaine is a drug that has been approved by the Food and Drug Administration (FDA). Sodium bicarbonate is an additive that buffers the acidity of lidocaine. The combination of the two is safe and ef...
Eligibility Criteria
Inclusion
- Ability to provide informed consent
- Women IUD placement for contraception or heavy menstrual bleeding
- Ages 18-50
- English-speaking
- Participants must not have a past medical history of substance use disorders, pain disorders, use of prescription pain medications or are found to be pregnant
Exclusion
- No history of vaginal delivery
- Current use of prescription pain medication prior to procedure. Over-the-counter medications such as those containing ibuprofen, aspirin, acetaminophen, or naproxen are allowed.
- Diagnosed chronic pain condition
- Current pregnancy
- Known allergic reactions to components of the local anesthetic
- History of an IUD placement
- Current substance use or history of substance use
- Known contraindications to IUD, such as unexplained vaginal bleeding
Key Trial Info
Start Date :
June 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT06960317
Start Date
June 4 2025
End Date
June 30 2028
Last Update
June 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
La Jolla, California, United States, 92093